David H. Munn MD
Professor, Pediatrics, Medical College of Georgia at Georgia Health Sciences
Join to View Full Profile
1120 15th StAugusta, GA 30912
Phone+1 706-721-3626
Fax+1 706-721-2643
Are you Dr. Munn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Munn, MD is a pediatric hematologist/oncologist in Augusta, Georgia. He is a Professor at Medical College of Georgia at Georgia Health Sciences.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1987 - 1990
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1984 - 1987
Medical College of Georgia at Augusta UniversityClass of 1984
Publications & Presentations
PubMed
- Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKR.Nobushige Tsuboi, Kimberly A Rivera-Caraballo, Upasana Sahu, Rafal Pacholczyk, Eugene Douglass
Molecular Cancer Therapeutics. 2025-03-04 - 17 citationsIndoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.Theodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, Dolly Aguilera, Ahmad Al-Basheer
Neuro-Oncology. 2024-02-02 - 7 citationsEnniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer.Nada H Eisa, Vincent M Crowley, Asif Elahi, Vamsi Krishna Kommalapati, Michael A Serwetnyk
Iscience. 2023-12-15
Press Mentions
- Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: ResearchApril 25th, 2023
- Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain TumorsApril 25th, 2023
- Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of PsoriasisFebruary 28th, 2022
- Join now to see all
Grant Support
- Chemo-radio immunotherapy for pediatric brain tumorsAUGUSTA UNIVERSITY2019–2025
- Reprogramming the TME for immunogenic antigen-presentationAUGUSTA UNIVERSITY2003–2025
